t

AI Summary

Trading on AIM for Beximco Pharmaceuticals Limited's Global Depositary Receipts was restored. The temporary suspension for these securities was lifted from 12 November 2024 at 10:00 am, following an announcement.

RNS Metadata

Date	12 Nov 2024
Time	10:00:00
Category	Corporate updates
ID	9070L

/Equities/AIMX/BXP/RNS

Restoration - Beximco Pharmaceuticals Limited

RNS Number : 9070L

AIM

12 November 2024

NOTICE

12/11/2024 10:00am

RESTORATION OF TRADING ON AIM

BEXIMCO PHARMACEUTICALS LIMITED

Trading on AIM for the under mentioned securities was temporarily suspended. The suspension is lifted from 12/11/2024 10:00am, an announcement having been made.

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0) 20 3368 3551.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

EXCGPGBCGUPCUBP

t

Company Information

AI Summary

RNS Metadata

Company Information

AI Summary

RNS Metadata

Restoration - Beximco Pharmaceuticals Limited